225 related articles for article (PubMed ID: 9659525)
1. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy.
Gillissen A; Nowak D
Respir Med; 1998 Apr; 92(4):609-23. PubMed ID: 9659525
[TBL] [Abstract][Full Text] [Related]
2. Oxidant scavenger function of ambroxol in vitro: a comparison with N-acetylcysteine.
Gillissen A; Schärling B; Jaworska M; Bartling A; Rasche K; Schultze-Werninghaus G
Res Exp Med (Berl); 1997; 196(6):389-98. PubMed ID: 9089888
[TBL] [Abstract][Full Text] [Related]
3. [Anti-inflammatory efficacy of N-acetylcysteine and therapeutic usefulness].
Gillissen A
Pneumologie; 2011 Sep; 65(9):549-57. PubMed ID: 21761386
[TBL] [Abstract][Full Text] [Related]
4. Effects of N-acetylcysteine and ambroxol on the production of IL-12 and IL-10 in human alveolar macrophages.
Aihara M; Dobashi K; Akiyama M; Naruse I; Nakazawa T; Mori M
Respiration; 2000; 67(6):662-71. PubMed ID: 11124650
[TBL] [Abstract][Full Text] [Related]
5. [Ambroxol].
Akkoca Yildiz O
Tuberk Toraks; 2006; 54 Suppl 1():3-14. PubMed ID: 17089236
[No Abstract] [Full Text] [Related]
6. [The application of n-acetylcysteine as an antioxidant and mucolytic in mechanical ventilation in intensive care patients. A prospective, randomized, placebo-controlled, double-blind study].
Konrad F; Schoenberg MH; Wiedmann H; Kilian J; Georgieff M
Anaesthesist; 1995 Sep; 44(9):651-8. PubMed ID: 7485927
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant function of ambroxol in mononuclear and polymorphonuclear cells in vitro.
Gillissen A; Bartling A; Schoen S; Schultze-Werninghaus G
Lung; 1997; 175(4):235-42. PubMed ID: 9195551
[TBL] [Abstract][Full Text] [Related]
8. Nacystelyn, a novel lysine salt of N-acetylcysteine, to augment cellular antioxidant defence in vitro.
Gillissen A; Jaworska M; Orth M; Coffiner M; Maes P; App EM; Cantin AM; Schultze-Werninghaus G
Respir Med; 1997 Mar; 91(3):159-68. PubMed ID: 9135855
[TBL] [Abstract][Full Text] [Related]
9. Mucolytics and antioxidant activity.
Strapková A; Nosál'ová G; Franová S
Life Sci; 1999; 65(18-19):1923-5. PubMed ID: 10576438
[TBL] [Abstract][Full Text] [Related]
10. A double-blind placebo controlled trial with oral ambroxol and N-acetylcysteine for mucolytic treatment in cystic fibrosis.
Ratjen F; Wönne R; Posselt HG; Stöver B; Hofmann D; Bender SW
Eur J Pediatr; 1985 Nov; 144(4):374-8. PubMed ID: 3908111
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of ambroxol against paraquat-induced pulmonary fibrosis in rats.
Zhi QM; Yang LT; Sun HC
Intern Med; 2011; 50(18):1879-87. PubMed ID: 21921364
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic use of N-acetylcysteine in acute lung diseases].
Domenighetti G; Quattropani C; Schaller MD
Rev Mal Respir; 1999 Feb; 16(1):29-37. PubMed ID: 10091258
[TBL] [Abstract][Full Text] [Related]
13. N-acetylcysteine and ambroxol inhibit endotoxin-induced phagocyte accumulation in rat lungs.
Nawrocka A; Papierz W; Bialasiewicz P; Stolarek R; Komos J; Nowak D
Pulm Pharmacol Ther; 1999; 12(6):369-75. PubMed ID: 10587478
[TBL] [Abstract][Full Text] [Related]
14. [The application of N-acetylcysteine in optimization of specific pharmacological therapies].
Hołyńska-Iwan I; Wróblewski M; Olszewska-Słonina D; Tyrakowski T
Pol Merkur Lekarski; 2017 Sep; 43(255):140-144. PubMed ID: 28987048
[TBL] [Abstract][Full Text] [Related]
15. Clinical applications of N-acetylcysteine.
Kelly GS
Altern Med Rev; 1998 Apr; 3(2):114-27. PubMed ID: 9577247
[TBL] [Abstract][Full Text] [Related]
16. Multifaceted activity of N-acetyl-l-cysteine in chronic obstructive pulmonary disease.
Calzetta L; Matera MG; Rogliani P; Cazzola M
Expert Rev Respir Med; 2018 Aug; 12(8):693-708. PubMed ID: 29972340
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation.
Cazzola M; Calzetta L; Facciolo F; Rogliani P; Matera MG
Respir Res; 2017 Jan; 18(1):26. PubMed ID: 28118826
[TBL] [Abstract][Full Text] [Related]
18. [N-acetylcysteine: a functional oxygen radical scavenger in vitro and ex vivo in monocytes and neutrophilic granulocytes of patients with COPD].
Jaworska M; Gillissen A; Schärling B; Wickenburg D; Schultze-Werninghaus G
Pneumologie; 1995 Oct; 49(10):539-45. PubMed ID: 8584524
[TBL] [Abstract][Full Text] [Related]
19. Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease.
Kasielski M; Nowak D
Respir Med; 2001 Jun; 95(6):448-56. PubMed ID: 11421501
[TBL] [Abstract][Full Text] [Related]
20. N-acetylcysteine attenuates the acute lung injury caused by phorbol myristate acetate in isolated rat lungs.
Chuang IC; Liu DD; Kao SJ; Chen HI
Pulm Pharmacol Ther; 2007; 20(6):726-33. PubMed ID: 17071120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
